{"schema_version":"secwatch.filing_event.v1","accession":"0000875320-23-000047","form_type":"8-K","ticker":"VRTX","cik":"0000875320","company_name":"VERTEX PHARMACEUTICALS INC / MA","filed_at":"2023-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.211334+00:00","generated_at":"2026-06-07T18:27:38.956708+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Vertex appoints Nancy Thornberry to board of directors","bullets":["Nancy Thornberry, former CEO of Kallyope and ex-Merck executive, joins the board effective December 5, 2023.","Board size increased from 10 to 11 members with Thornberry's appointment.","Thornberry received a $400,000 restricted stock unit award vesting in December 2024.","No related party transactions or arrangements with any other persons were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000875320-23-000047","json":"https://secwatch.observer/filing/0000875320-23-000047.json","markdown":"https://secwatch.observer/filing/0000875320-23-000047.md","text":"https://secwatch.observer/filing/0000875320-23-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000047/0000875320-23-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000047/vrtx-20231205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T18:27:38.956708+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c98382c7e","claim":"Nancy Thornberry was appointed as member of the board of directors at VERTEX PHARMACEUTICALS INC / MA.","evidence_excerpt":"On December 5, 2023, Nancy Thornberry was appointed as a new member of the board of directors (the “Board”) of Vertex Pharmaceuticals Incorporated (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000047/0000875320-23-000047-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}